1. Lahoti A, Harris YT, Speiser PW, Atsidaftos E, Lipton JM, Vlachos A. 2016; Endocrine dysfunction in Diamond-Blackfan Anemia (DBA): a report from the DBA Registry (DBAR). Pediatr Blood Cancer. 63:306–312. DOI:
10.1002/pbc.25780. PMID:
26496000. PMCID:
PMC4829065.
Article
2. Matyjaszek-Matuszek B, Mieszkowska A, Lenart-Lipinska M, Ben-Skowronek I, Tarach J. 2016; Hypopituitarism in the course of secondary hemochromatosis in a patient with Diamond-Blackfan anemia. Endocr Abstr. 41:EP278. DOI:
10.1530/endoabs.41.EP278.
Article
3. Engidaye G, Melku M, Enawgaw B. 2019; Diamond Blackfan anemia: genetics, pathogenesis, diagnosis and treatment. EJIFCC. 30:67–81. PMID:
30881276. PMCID:
PMC6416817.
5. Howell JC, Joshi SA, Hornung L, Khoury J, Harris RE, Rose SR. 2015; Growth hormone improves short stature in children with Diamond-Blackfan anemia. Pediatr Blood Cancer. 62:402–408. DOI:
10.1002/pbc.25341. PMID:
25492299.
Article
7. Chae H, Park J, Kim M, Lim J, Kim Y, Han K, et al. 2010; Diamond-Blackfan anemia confirmed by RPS19 gene mutation analysis: a case study and literature review of Korean patients. Korean J Lab Med. 30:249–254. DOI:
10.3343/kjlm.2010.30.3.249. PMID:
20603584.
Article
8. Talla MR, McIlwaine L, Panarelli M, Hughes K. 2016; Endocrine dysfunction in Blackfan Anaemia. Endocr Abst. 44:EP58. DOI:
10.1530/endoabs.44.EP58.